2,4-octadienal: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 5283329 |
| CHEBI ID | 165523 |
| SCHEMBL ID | 225646 |
| SCHEMBL ID | 225645 |
| MeSH ID | M0450037 |
| Synonym |
|---|
| 2,4-octadienal, (e,e)- |
| trans,trans-octa-2,4-dienal |
| 2,4-octadienal |
| octa-2,4-dienal |
| 2,4-octadienal, predominantly trans,trans, >=95%, fg |
| LMFA06000034 |
| 5577-44-6 |
| (2e,4e)-octa-2,4-dienal |
| (e,e)-2,4-octadienal |
| CHEBI:165523 |
| octadienal |
| 30361-28-5 |
| A820344 |
| A830802 |
| 38743-20-3 |
| 2,4-octadienal, (2e,4e)- |
| fema no. 3721 |
| 2,4-octadienal, trans,trans- |
| einecs 250-147-1 |
| (e,e)-2,4-octadien-1-al |
| pr4j26tqjd , |
| unii-pr4j26tqjd |
| trans,trans-2,4-octadienal |
| 2.4-octadienal |
| 2e,4e-octadienal |
| (2e,4e)-2,4-octadienal |
| AKOS015899862 |
| SCHEMBL225646 |
| SCHEMBL225645 |
| trans,trans-2,4-octadienal [fhfi] |
| 2,4-octadien-1-al, (e,e)- |
| DVVATNQISMINCX-UHFFFAOYSA-N |
| (e)-2,(e)-4-octadienal |
| DVVATNQISMINCX-YTXTXJHMSA-N |
| (e,e)-octa-2,4-dienal |
| 2,4-octadien-1-al |
| fema 3721 |
| DS-18477 |
| mfcd00014676 |
| D71091 |
| Q27286719 |
| DTXSID00885475 |
| CS-0186044 |
| EN300-1867374 |
| EN300-7380375 |
| Excerpt | Reference | Relevance |
|---|---|---|
| " In comparison with studies reported in the literature, contrasting results were observed during our tests; therefore, an increasing toxic effect was registered with decreasing the chain length of aldehydes." | ( Toxicity of polyunsaturated aldehydes of diatoms to Indo-Pacific bioindicator organism Echinometra mathaei. Gaion, A; Sartori, D, 2016) | 0.43 |
| Class | Description |
|---|---|
| fatty aldehyde | An aldehyde formally arising from reduction of the carboxylic acid group of its corresponding fatty acid, having a carbonyl group at one end of the carbon chain. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (21.66) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 9 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||